Christine Rouzioux

24.9k total citations · 4 hit papers
280 papers, 15.3k citations indexed

About

Christine Rouzioux is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Christine Rouzioux has authored 280 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 231 papers in Virology, 225 papers in Infectious Diseases and 66 papers in Epidemiology. Recurrent topics in Christine Rouzioux's work include HIV Research and Treatment (231 papers), HIV/AIDS Research and Interventions (182 papers) and HIV/AIDS drug development and treatment (140 papers). Christine Rouzioux is often cited by papers focused on HIV Research and Treatment (231 papers), HIV/AIDS Research and Interventions (182 papers) and HIV/AIDS drug development and treatment (140 papers). Christine Rouzioux collaborates with scholars based in France, United States and Ivory Coast. Christine Rouzioux's co-authors include Marie‐Laure Chaix, Véronique Avettand-Fènoël, Jean‐François Delfraissy, Stéphane Blanche, Marianne Burgard, Laurence Meyer, Cécile Goujard, Luc Montagnier, David Klatzmann and Jean‐Paul Viard and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Christine Rouzioux

274 papers receiving 14.8k citations

Hit Papers

Isolation of a New Human ... 1984 2026 1998 2012 1986 1984 1996 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Rouzioux France 66 10.4k 10.3k 4.4k 3.6k 2.0k 280 15.3k
Joel E. Gallant United States 56 9.7k 0.9× 11.9k 1.2× 4.3k 1.0× 1.8k 0.5× 3.4k 1.7× 156 15.8k
Robert W. Coombs United States 59 8.9k 0.9× 11.8k 1.1× 5.7k 1.3× 1.6k 0.4× 1.8k 0.9× 235 16.8k
David Katzenstein United States 60 9.5k 0.9× 11.5k 1.1× 3.6k 0.8× 906 0.3× 1.7k 0.8× 281 15.2k
Jean‐François Delfraissy France 53 5.7k 0.5× 5.2k 0.5× 2.7k 0.6× 3.3k 0.9× 1.2k 0.6× 193 10.2k
Huldrych F. Günthard Switzerland 72 13.7k 1.3× 13.2k 1.3× 4.3k 1.0× 3.0k 0.8× 2.0k 1.0× 371 19.3k
Alfred J. Saah United States 57 4.8k 0.5× 5.3k 0.5× 6.4k 1.5× 2.7k 0.7× 1.2k 0.6× 165 13.6k
Charles R. Rinaldo United States 66 9.4k 0.9× 8.0k 0.8× 7.2k 1.6× 6.6k 1.8× 1.4k 0.7× 347 19.6k
Sharon R. Lewin Australia 67 9.9k 0.9× 8.0k 0.8× 6.6k 1.5× 5.8k 1.6× 2.6k 1.3× 370 19.0k
Timothy W. Schacker United States 55 10.3k 1.0× 6.3k 0.6× 4.3k 1.0× 6.5k 1.8× 2.2k 1.1× 119 15.3k
P. Richard Harrigan Canada 55 7.2k 0.7× 8.5k 0.8× 3.1k 0.7× 795 0.2× 1.3k 0.6× 236 10.8k

Countries citing papers authored by Christine Rouzioux

Since Specialization
Citations

This map shows the geographic impact of Christine Rouzioux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Rouzioux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Rouzioux more than expected).

Fields of papers citing papers by Christine Rouzioux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Rouzioux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Rouzioux. The network helps show where Christine Rouzioux may publish in the future.

Co-authorship network of co-authors of Christine Rouzioux

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Rouzioux. A scholar is included among the top collaborators of Christine Rouzioux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Rouzioux. Christine Rouzioux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gharu, Lavina, Anna Kula, Alexander Pasternak, et al.. (2018). Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. mBio. 9(6). 30 indexed citations
2.
Scott‐Algara, Daniel, Josiane Warszawski, Jérôme Le Chenadec, et al.. (2016). Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP Study. AIDS Research and Human Retroviruses. 33(1). 21–28.
3.
Assoumou, Lambert, Laurence Weiss, Christophe Piketty, et al.. (2015). A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control. AIDS. 29(15). 2003–2007. 61 indexed citations
4.
Aupiais, Camille, Albert Faye, Jérôme Le Chenadec, et al.. (2014). Interruption of cART in Clinical Practice Is Associated With an Increase in the Long-Term Risk of Subsequent Immunosuppression in HIV-1-Infected Children. The Pediatric Infectious Disease Journal. 33(12). 1237–1245. 3 indexed citations
5.
Toni, Thomas d’Aquin, Sophie Desmonde, Clarisse Amani‐Bosse, et al.. (2013). Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d’Ivoire. The Pedi-Test DBS ANRS 12183 Study. Journal of Virological Methods. 193(2). 439–445. 8 indexed citations
6.
Tsiara, Chrissa, Georgios K. Nikolopoulos, Pantelis G. Bagos, et al.. (2011). Impact of HIV Type 1 DNA Levels on Spontaneous Disease Progression: A Meta-Analysis. AIDS Research and Human Retroviruses. 28(4). 366–373. 17 indexed citations
7.
Briand, Nelly, Laurent Mandelbrot, Stéphane Blanche, et al.. (2011). Previous Antiretroviral Therapy for Prevention of Mother-to-Child Transmission of HIV Does not Hamper the Initial Response to PI-Based Multitherapy During Subsequent Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(2). 126–135. 8 indexed citations
8.
Hocqueloux, Laurent, Thiérry Prazuck, Véronique Avettand-Fènoël, et al.. (2010). Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS. 24(10). 1598–1601. 149 indexed citations
9.
Galimand, Julie, Pierre Frange, Christine Rouzioux, et al.. (2010). Short Communication: Evidence of HIV Type 1 Complex and Second Generation Recombinant Strains Among Patients Infected in 1997–2007 in France: ANRS CO06 PRIMO Cohort. AIDS Research and Human Retroviruses. 26(6). 645–651. 16 indexed citations
10.
Vaz, Paula, Marie‐Laure Chaix, Ilesh Jani, et al.. (2009). Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. The Pediatric Infectious Disease Journal. 28(12). e283–e287. 21 indexed citations
11.
Vidal, Nicole, Pierre Frange, Marie‐Laure Chaix, et al.. (2008). Characterization of an Old Complex Circulating Recombinant Form, CRF27_cpx, Originating from the Democratic Republic of Congo (DRC) and Circulating in France. AIDS Research and Human Retroviruses. 24(2). 315–321. 14 indexed citations
12.
Goujard, Cécile, Fabienne Marcellin, Houria Hendel‐Chavez, et al.. (2007). Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study. AIDS Research and Human Retroviruses. 23(9). 1105–1113. 39 indexed citations
13.
Lévy, Yves, Christine Durier, Anne‐Sophie Lascaux, et al.. (2006). Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals. AIDS. 20(3). 405–413. 65 indexed citations
14.
Buseyne, Florence, Jérôme Le Chenadec, Marianne Burgard, et al.. (2005). In HIV Type 1-Infected Children Cytotoxic T Lymphocyte Responses Are Associated with Greater Reduction of Viremia under Antiretroviral Therapy. AIDS Research and Human Retroviruses. 21(8). 719–727. 8 indexed citations
15.
Lichtner, Miriam, Concepción Marañón, Olga Azocar, et al.. (2004). HIV Type 1-Infected Dendritic Cells Induce Apoptotic Death in Infected and Uninfected Primary CD4 T Lymphocytes. AIDS Research and Human Retroviruses. 20(2). 175–182. 69 indexed citations
16.
Ngo‐Giang‐Huong, Nicole, Daniel Candotti, Aïcha Goubar, et al.. (2001). HIV Type 1-Specific IgG2 Antibodies: Markers of Helper T Cell Type 1 Response and Prognostic Marker of Long-Term Nonprogression. AIDS Research and Human Retroviruses. 17(15). 1435–1446. 71 indexed citations
17.
Mandelbrot, Laurent, Claire Rekacewicz, Alain Berrébi, et al.. (2001). Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1. Obstetrical & Gynecological Survey. 56(10). 603–604. 5 indexed citations
18.
Burgard, Marianne, Jacques Izopet, Catherine Tamalet, et al.. (2000). HIV RNA and HIV DNA in Peripheral Blood Mononuclear Cells Are Consistent Markers for Estimating Viral Load in Patients Undergoing Long-Term Potent Treatment. AIDS Research and Human Retroviruses. 16(18). 1939–1947. 41 indexed citations
19.
Sperling, Rhoda, David E. Shapiro, Robert W. Coombs, et al.. (1997). Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. Obstetrical & Gynecological Survey. 52(5). 277–278. 41 indexed citations
20.
Sperling, Rhoda, David E. Shapiro, Robert W. Coombs, et al.. (1996). Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. New England Journal of Medicine. 335(22). 1621–1629. 587 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026